PEOPLE - Aastrom Biosciences (US) makes appointment:
This article was originally published in Clinica
Aastrom Biosciences (Ann Arbor, Michigan), a developer of proprietary cell therapeutic products, has appointed Michael Durski as vice-president of finance and administration and CFO. Mr Durski, who has over 25 years of financial and management experience, most recently served as chairman, CEO and CFO of ZeptoMetrix. Ronald Dudek, who has over 12 years of experience in the biotechnology and medical device industry, has been appointed director of sales and marketing.
You may also be interested in...
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.